Please login to the form below

Not currently logged in
Email:
Password:

mCNV

This page shows the latest mCNV news and features for those working in and with pharma, biotech and healthcare.

Lucentis claims speedy FDA review for myopia complication

Lucentis claims speedy FDA review for myopia complication

Eylea is not yet approved for mCNV in the US, although Bayer has a green light for this use in Europe and so is already competing head-to-head with Novartis

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

Congress Effectiveness Management
Maximising the ROI of scientific meetings...
Shanghai
Biopharma's Future: Made in China
The world’s second biggest pharma market is entering a new growth phase – but meeting its needs takes investment and expertise...
Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...

Infographics